Tenaya Therapeutics, Inc.
TNYA
$0.72
$0.011.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.87% | 7.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.33% | -0.77% | |||
| Operating Income | 3.42% | 0.77% | |||
| Income Before Tax | 4.48% | 0.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.48% | 0.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.48% | 0.49% | |||
| EBIT | 3.42% | 0.77% | |||
| EBITDA | 3.41% | 0.65% | |||
| EPS Basic | 22.90% | 7.09% | |||
| Normalized Basic EPS | 22.92% | 7.22% | |||
| EPS Diluted | 22.90% | 7.09% | |||
| Normalized Diluted EPS | 22.92% | 7.22% | |||
| Average Basic Shares Outstanding | 23.90% | 7.16% | |||
| Average Diluted Shares Outstanding | 23.90% | 7.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||